Literature DB >> 344088

A comparison of naproxen, indomethacin and acetylsalicylic acid in pain after varicose vein surgery.

U Aromaa, K Asp.   

Abstract

Oral naproxen in doses of 500 mg and 750 mg daily was compared with oral indomethacin, 75 mg daily, in a double-blind, completely randomized study of patients with post-operative pain after out-patients varicose vein surgery. Altogether, 120 patients were studied. In the study 750 mg naproxen proved to be equal in respect of analgesic efficacy to 75 mg indomethacin, and it was clearly superior to 1500 mg acetylsalicylic acid. Naproxen, 500 to 750 mg daily, afforded adequate post-operative analgesia in 98% of patients. The side-effects were mild. On the basis of the study, naproxen can be recommended as a pain-relieving drug after minor surgery, particularly when an antiphlogistic effect is also desirable.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 344088     DOI: 10.1177/030006057800600216

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  5 in total

1.  Mild analgesics in postoperative pain.

Authors:  T Tammisto; I Tigerstedt
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

Review 2.  Single dose oral indometacin for the treatment of acute postoperative pain.

Authors:  L Mason; J Edwards; R A Moore; H J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

Review 3.  Single dose oral naproxen and naproxen sodium for acute postoperative pain.

Authors:  L Mason; J E Edwards; R A Moore; H J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

Review 4.  Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-10       Impact factor: 9.546

Review 5.  Single dose oral aspirin for acute postoperative pain in adults.

Authors:  Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.